home / stock / lgvn / lgvn articles

LGVN Articles, Longeveron Inc. - From 04/08/24

Stock Information
Company Name: Longeveron Inc.
Stock Symbol: LGVN
Market: NASDAQ
Website: longeveron.com
Menu
LGVN LGVN Quote LGVN Short LGVN News LGVN Articles LGVN Message Board
Get LGVN Alerts

News, Short Squeeze, Breakout and More Instantly...
Gold Moves Higher; Auddia Shares Surge | Benzinga

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday. The Dow traded up 0.04% to 38,919.32 ...
Why Longeveron (LGVN) Stock Exploded Higher Today | Benzinga

Longeveron Inc (NASDAQ:LGVN) shares traded upwards of 50% Monday after the company announced they submitted paperwork for a share offering and anno...

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. A...

Crude Oil Moves Lower; Perion Network Shares Tumble | Benzinga

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded up 0.21% to 38,983.94 ...
US Stocks Higher; Dow Gains Over 50 Points | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Monday. Following the market opening Monday, the Dow tra...

Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new ...

Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. RH posted weaker-than-expecte...
Longeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024 | Benzinga

MIAMI, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnolo...

Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™ | Benzinga

MIAMI, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company devel...

Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying | Benzinga

The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern a...
Previous 10 Next 10